Eterna Therapeutics shares are trading higher after the company announced results from a preclinical study on ERNA-101.

Eterna Therapeutics +9.81% Post

Eterna Therapeutics

ERNA

0.29

0.31

+9.81%

+7.71% Post

Eterna Therapeutics shares are trading higher after the company announced results from a preclinical study on ERNA-101.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via